- STOCKHOLDERS' EQUITY	9 Months Ended
Apr. 30, 2020
- STOCKHOLDERS' EQUITY [Abstract]
- STOCKHOLDERS' EQUITY	NOTE 4 - STOCKHOLDERS' EQUITY Upon formation, the total number of shares of all classes of stock which the Company is authorized to issue is seventy-five million (75,000,000) shares of Common Stock, par value $0.001 per share. On September 4, 2018, the Company issued 3,500,000 shares of common stock to its President and Incorporator, Mr. Olegas Tunevicius, at $0.001 per share, which reduced the note payable due to him by $3,500. During July 2019 the Company issued 72,500 shares of common stock for cash proceeds of $1,450 at $0.02 per share. During the nine months ended April 30, 2020, the Company issued 439,050 shares of common stock for cash proceeds of $8,781 at $0.02 per share. There were 4,011,550 and 3,572,500 shares of common stock issued and outstanding as of April 30, 2020, and July 31, 2019.

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762

Name:	us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration